Company & Sponsor Intelligence

National Neuroscience Institute

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials3

Recruiting2

Completed1

Countries1

Therapeutic footprint

alzheimersneuro_oncologyparkinsons

Indexed studies

NCT06894225Proof-of-Concept Study of ACT001 in Adult Patients With Recurrent Glioblastoma Harbouring STAT3-High Signature
neuro_oncology · SingaporePHASE2

NCT02444637Open Label Trial of Rivastigmine Patch in Subjects With Mild to Moderate Stage AD Having Coexisting svCVD
alzheimers · SingaporePHASE4

NCT04491383Tocotrienols in Parkinson's Disease (PD)
parkinsons · SingaporePHASE2

Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →